Education
About Us
Working with TipRanks
Follow Us
Peter Pfreundschuh Insider Profile
4 Followers
Peter Pfreundschuh, Chief Financial Officer at Immunomedics, holds 77.80K shares in Y-Mabs Therapeutics (Ticker: YMAB), holds 175.67K shares in Voyager Therapeutics (Ticker: VYGR), holds 8.93K shares in Korro Bio (Ticker: KRRO).
Peter Pfreundschuh Immunomedics (IMMU)Chief Financial Officer
Immunomedics (IMMU)
Chief Financial Officer
Ranked #9,825 out of 100,956 Corporate Insiders
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+52.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Peter Pfreundschuh holds in companies
Most Profitable Insider Trade
The most profitable trade made by Peter Pfreundschuh
Peter Pfreundschuh's Trading History
Immunomedics
Aug 24, 2015
―
Uninformative Buy
―
$2.61M
Sucampo Pharmaceuticals
Feb 13, 2018
―
Uninformative Sell
4.73K
$0.00
Urogen Pharma
Oct 16, 2020
CFO
Uninformative Buy
57.21K
$102.18K
Korro Bio
Feb 23, 2022
CFO
Informative Sell
10.86K
$199.34K
Voyager Therapeutics
Feb 22, 2024
CFO
Informative Sell
28.08K
$748.35K
Y-Mabs Therapeutics
Jan 22, 2025
CFO & Treasurer
Uninformative Buy
―
$401.45K
List of latest transactions for each holding click on a transaction to see Peter Pfreundschuh's performance on stock
You May Also Like
Peter Pfreundschuh insider profile FAQ
What is the percentage of profitable transactions made by Peter Pfreundschuh?
The percentage of profitable transactions made by Peter Pfreundschuh is 100%.
What is the average return per transaction made by Peter Pfreundschuh?
The average return per transaction made by Peter Pfreundschuh is 52.20%.
What stocks does Peter Pfreundschuh hold?
Peter Pfreundschuh holds: IMMU, SCMP, URGN, KRRO, VYGR, YMAB stocks.
What was Peter Pfreundschuh’s latest transaction?
Peter Pfreundschuh latest transaction was an Uninformative Buy of ―.
What was Peter Pfreundschuh's most profitable transaction?
Peter Pfreundschuh’s most profitable transaction was an Informative Sell of KRRO stock on February 18, 2022. The return on the trade was 82.60%.
What is Peter Pfreundschuh's role in Immunomedics?
Peter Pfreundschuh's role in Immunomedics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.